These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18881491)

  • 21. Immunological properties of hyaluronidases associated with temperate bacteriophages of group A streptococci.
    Benchetrit LC; Wannamaker LW; Gray ED
    J Exp Med; 1979 Jan; 149(1):73-83. PubMed ID: 368286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the pathogenicity of group A Streptococci. I. Its relation to surface phagocytosis.
    FOLEY MJ; SMITH MR; WOOD WB
    J Exp Med; 1959 Oct; 110(4):603-16. PubMed ID: 13823727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ANTIGENIC DIFFERENCES BETWEEN MATT HEMOLYTIC STREPTOCOCCI AND THEIR GLOSSY VARIANTS.
    Lancefield RC; Todd EW
    J Exp Med; 1928 Nov; 48(6):769-90. PubMed ID: 19869520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyaluronidase production by groups A, B, C, and G streptococci: a statistical analysis.
    Benchetrit LC; Avelino CC; Barrucand L; Sá Figueiredo AM; de Oliveira CM
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):27-37. PubMed ID: 6380153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on Streptococcus pyogenes. IV. Effect of whole cells, M and C antigens, and other components of the cell on adrenalectomized rats.
    SLADE HD; KIMURA Y
    J Exp Med; 1959 Jun; 109(6):589-600. PubMed ID: 13654630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.
    Schrager HM; Rheinwald JG; Wessels MR
    J Clin Invest; 1996 Nov; 98(9):1954-8. PubMed ID: 8903312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence of group A streptococci for mice in relation to the production and destruction of hyaluronic acid.
    PIKE RM
    J Infect Dis; 1948; 83(1):19-22. PubMed ID: 18869803
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of hyaluronidase in subcutaneous spread and growth of group A streptococcus.
    Starr CR; Engleberg NC
    Infect Immun; 2006 Jan; 74(1):40-8. PubMed ID: 16368955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronic acid utilization by hemolytic streptococci in relation to possible hyaluronidase function in pathogenesis.
    SALLMAN B; BIRKELAND JM; GRAY CT
    Proc Soc Exp Biol Med; 1951 Mar; 76(3):467-71. PubMed ID: 14844243
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.
    Ashbaugh CD; Warren HB; Carey VJ; Wessels MR
    J Clin Invest; 1998 Aug; 102(3):550-60. PubMed ID: 9691092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the chain length of group A streptococci. I. Demonstration of a metabolically active chain-splitting system.
    EKSTEDT RD; STOLLERMAN GH
    J Exp Med; 1960 Oct; 112(4):671-86. PubMed ID: 13726267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive acquired mucosal immunity to group A streptococci by secretory immunoglobulin A.
    Bessen D; Fischetti VA
    J Exp Med; 1988 Jun; 167(6):1945-50. PubMed ID: 3290383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EFFECT OF SUBLETHAL CONCENTRATIONS OF PENICILLIN ON THE VIRULENCE AND ANTIGENIC COMPOSITION OF GROUP A STREPTOCOCCI.
    MICHAEL JG; MASSELL BF; PERKINS RE
    J Bacteriol; 1963 Jun; 85(6):1280-7. PubMed ID: 14047218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessory plasma factors involved in the bactericidal test for type-specific antibody to group A Streptococci. II. Human plasma cofactor (s) enhancing opsonization of encapsulated organisms.
    STOLLERMAN GH; RYTEL M; ORTIZ J
    J Exp Med; 1963 Jan; 117(1):1-17. PubMed ID: 13984363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of chicken embryos to group A streptococci: correlation with fibrinogen binding.
    Schmidt KH; Wiesner J; Gerlach D; Reichardt W; Ozegowski JH; Köhler W
    FEMS Immunol Med Microbiol; 1993 Oct; 7(3):231-40. PubMed ID: 8275054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronate capsule prevents attachment of group A streptococci to mouse peritoneal macrophages.
    Whitnack E; Bisno AL; Beachey EH
    Infect Immun; 1981 Mar; 31(3):985-91. PubMed ID: 7014469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spa contributes to the virulence of type 18 group A streptococci.
    McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
    Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TYPE-SPECIFIC ANTIGENS, M AND T, OF MATT AND GLOSSY VARIANTS OF GROUP A HEMOLYTIC STREPTOCOCCI.
    Lancefield RC
    J Exp Med; 1940 Mar; 71(4):521-37. PubMed ID: 19870978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Streptococcal-hyaluronidase. V. The effect of penicillin on the production of hyaluronic acid and hyaluronidase by hemolytic streptococci (type 28, group A).
    ROSENDAL K; FABER V
    Acta Pathol Microbiol Scand; 1955; 37(3):293-9. PubMed ID: 13258240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.